BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4271 related articles for article (PubMed ID: 1292642)

  • 1. High serum levels of TNF-alpha after its administration for isolation perfusion of the limb.
    Gérain J; Liénard D; Ewalenko P; Lejeune FJ
    Cytokine; 1992 Nov; 4(6):585-91. PubMed ID: 1292642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.
    Laurenzi L; Natoli S; Di Filippo F; Calamaro A; Centulio F; Anzà M; Cavaliere F; Marcelli ME; Garinei R; Arcuri E
    J Exp Clin Cancer Res; 2004 Jun; 23(2):225-31. PubMed ID: 15354406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan.
    Kettelhack C; Hohenberger P; Schulze G; Kilpert B; Schlag PM
    Crit Care Med; 2000 Apr; 28(4):1040-6. PubMed ID: 10809279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage.
    Stam TC; Swaak AJ; de Vries MR; ten Hagen TL; Eggermont AM
    Ann Surg Oncol; 2000 May; 7(4):268-75. PubMed ID: 10819366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Procalcitonin as marker of systemic inflammatory reaction after isolated extremity perfusion].
    Kettelhack C; Hohenberger P; Furchtbar S; Schulze G; Schlag PM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):399-402. PubMed ID: 14518284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan.
    Thom AK; Alexander HR; Andrich MP; Barker WC; Rosenberg SA; Fraker DL
    J Clin Oncol; 1995 Jan; 13(1):264-73. PubMed ID: 7799030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.
    Feelders RA; Vreugdenhil G; Eggermont AM; Kuiper-Kramer PA; van Eijk HG; Swaak AJ
    Eur J Clin Invest; 1998 Jul; 28(7):520-7. PubMed ID: 9726030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
    Lienard D; Ewalenko P; Delmotte JJ; Renard N; Lejeune FJ
    J Clin Oncol; 1992 Jan; 10(1):52-60. PubMed ID: 1727926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of continuous leakage monitoring with radioactive iodine-131-labeled human serum albumin during hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    van Ginkel RJ; Limburg PC; Piers DA; Koops HS; Hoekstra HJ
    Ann Surg Oncol; 2002 May; 9(4):355-63. PubMed ID: 11986187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
    Gérain J; Liénard D; Pampallona S; Baumgartner M; Rüegg C; Buurman WA; Eggermont A; Lejeune F
    Cytokine; 1997 Dec; 9(12):1034-42. PubMed ID: 9417816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of isolated limb perfusion with tumor necrosis factor-alpha on circulating levels of proinflammatory cytokines.
    Ferroni P; Di Filippo F; Martini F; Spila A; D'Alessandro T; Cavaliere F; Anzà M; Garinei R; Aloe S; Carone MD; Gazzaniga PP; Guadagni F
    J Immunother; 2001; 24(4):354-62. PubMed ID: 11565837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic leakage and side effects of tumor necrosis factor alpha administered via isolated limb perfusion can be manipulated by flow rate adjustment.
    Sorkin P; Abu-Abid S; Lev D; Gutman M; Aderka D; Halpern P; Setton A; Kudlik N; Bar-On J; Rudich V
    Arch Surg; 1995 Oct; 130(10):1079-84. PubMed ID: 7575120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid increase in plasma tenascin-C concentration after isolated limb perfusion with high-dose tumor necrosis factor (TNF), interferon gamma (IFN gamma) and melphalan for regionally advanced tumors.
    Schienk S; Liénard D; Gerain J; Baumgartner M; Lejeune FJ; Chiquet-Ehrismann R; Rüegg C
    Int J Cancer; 1995 Nov; 63(5):665-72. PubMed ID: 7591283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifyllin attenuates the systemic inflammatory response induced during isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan.
    Hohenberger P; Latz E; Kettelhack C; Rezaei AH; Schumann R; Schlag PM
    Ann Surg Oncol; 2003 Jun; 10(5):562-8. PubMed ID: 12794024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of isolated limb perfusion with tumour necrosis factor-alpha on the function of monocytes and T lymphocytes in patients with cancer.
    Stam TC; Jongen-Lavrencic M; Eggermont AM; Swaak AJ
    Eur J Clin Invest; 1996 Dec; 26(12):1085-91. PubMed ID: 9013083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
    Vrouenraets BC; Kroon BB; Ogilvie AC; van Geel AN; Nieweg OE; Swaak AJ; Eggermont AM
    Ann Surg Oncol; 1999 Jun; 6(4):405-12. PubMed ID: 10379864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolated limb perfusion with tumor necrosis factor for malignancies of the limbs].
    Abu-Abid S; Gutman M; Lev D; Inbar M; Chaitchik S; Sorkine P; Rudick V; Meller I; Klausner JM
    Harefuah; 1996 Oct; 131(7-8):227-32, 296, 295. PubMed ID: 8940515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized procedure of real-time systemic leakage monitoring during isolated limb perfusion using a hand held gamma probe and 99mTc-HSA.
    Casara D; Rubello D; Pilati P; Scalerta R; Foletto M; Rossi CR
    Nucl Med Commun; 2004 Jan; 25(1):61-6. PubMed ID: 15061266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated limb perfusion: distinct tourniquet and tumor necrosis factor effects on the early hemodynamic response.
    Christoforidis D; Chassot PG; Mosimann F; Lienard D; Brunstein F; Bejko D; Lejeune FJ; Chiolero R
    Arch Surg; 2003 Jan; 138(1):17-25. PubMed ID: 12511144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF dose reduction in isolated limb perfusion.
    Grünhagen DJ; de Wilt JH; van Geel AN; Graveland WJ; Verhoef C; Eggermont AM
    Eur J Surg Oncol; 2005 Nov; 31(9):1011-9. PubMed ID: 16099618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 214.